Xencor (XNCR) Common Equity (2013 - 2026)
Xencor's Common Equity came in at $503.23 million for Q2 2026, down 18.9% from $620.35 million a year earlier and down 2.4% from the prior quarter.
Analysis
Xencor (XNCR) Common Equity (2013 - 2026) Analysis & Trends
At the end of FY2025, Xencor's Common Equity was $635.59 million, down 5.7% from FY2024.
- Common Equity carries a five-year compound annual growth rate of 2.1% (FY2020 to FY2025).
- Going back by year, Common Equity was $674.03 million in FY2024 (+1.8%), $662.09 million in FY2023 (-9.0%), $727.5 million in FY2022 (-0.8%) and $733.5 million in FY2021 (+28.1%).
- The Q2 2026 figure represents the lowest quarterly Common Equity since Q4 2017.
- Year-over-year, Common Equity has declined for four consecutive quarters, with an average decline of 3.5% over the last eight quarters.
- The fastest year-over-year change in Common Equity over five years came in Q1 2022 (growth of 30.7%), and the weakest in Q1 2026 (a decline of 19.4%).
- Business Quant data shows XNCR's Common Equity at $515.63 million (Q1 2026), $635.59 million (Q4 2025) and $625.32 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Xencor | 1.86 Bn | 274.02 Mn | - | 503.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 503.23 Mn |
| Mar 31, 2026 | 515.63 Mn |
| Dec 31, 2025 | 635.59 Mn |
| Sep 30, 2025 | 625.32 Mn |
| Jun 30, 2025 | 620.35 Mn |
| Mar 31, 2025 | 639.87 Mn |
| Dec 31, 2024 | 674.03 Mn |
| Sep 30, 2024 | 705.93 Mn |
| Jun 30, 2024 | 548.71 Mn |
| Mar 31, 2024 | 599.73 Mn |
| Dec 31, 2023 | 662.09 Mn |
| Sep 30, 2023 | 669.01 Mn |
| Jun 30, 2023 | 678.88 Mn |
| Mar 31, 2023 | 683.58 Mn |
| Dec 31, 2022 | 727.50 Mn |
| Sep 30, 2022 | 722.70 Mn |
| Jun 30, 2022 | 742.34 Mn |
| Mar 31, 2022 | 763.02 Mn |
| Dec 31, 2021 | 733.50 Mn |
| Sep 30, 2021 | 618.86 Mn |
API Access
Xencor Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=XNCR&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "XNCR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=XNCR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();